端粒
再生障碍性贫血
髓系白血病
7号染色体(人类)
生物
端粒酶
骨髓衰竭
单体
癌症研究
髓样
非整倍体
先天性角化不良
基因突变
突变
造血
免疫学
染色体不稳定性
干细胞
骨髓
遗传学
染色体
基因
核型
作者
Bogdan Dumitriu,Xingmin Feng,Danielle Michelle Townsley,Yasutaka Ueda,Tetsuichi Yoshizato,Rodrigo T. Calado,Yanqin Yang,Yoshiyuki Wakabayashi,Sachiko Kajigaya,Seishi Ogawa,Jun Zhu,Neal S. Young
出处
期刊:Blood
[Elsevier BV]
日期:2014-11-19
卷期号:125 (4): 706-709
被引量:92
标识
DOI:10.1182/blood-2014-10-607572
摘要
The pathophysiology of severe aplastic anemia (SAA) is immune-mediated destruction of hematopoietic stem and progenitor cells (HSPCs). Most patients respond to immunosuppressive therapies, but a minority transform to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), frequently associated with monosomy 7 (-7). Thirteen SAA patients were analyzed for acquired mutations in myeloid cells at the time of evolution to -7, and all had a dominant HSPC clone bearing specific acquired mutations. However, mutations in genes associated with MDS/AML were present in only 4 cases. Patients who evolved to MDS and AML showed marked progressive telomere attrition before the emergence of -7. Single telomere length analysis confirmed accumulation of short telomere fragments of individual chromosomes. Our results indicate that accelerated telomere attrition in the setting of a decreased HSPC pool is characteristic of early myeloid oncogenesis, specifically chromosome 7 loss, in MDS/AML after SAA, and provides a possible mechanism for development of aneuploidy.
科研通智能强力驱动
Strongly Powered by AbleSci AI